American Association for the Advancement of Science, Science Translational Medicine, 524(12), 2020
DOI: 10.1126/scitranslmed.aax7533
Full text: Unavailable
Circulating tumor DNA methylation–based signatures are potential biomarkers for early diagnosis and prognosis of colorectal cancer.